Preclinical evidence and possible mechanisms of β-asarone for rats and mice with Alzheimer's disease: A systematic review and meta-analysis
Background: Currently, there are many different drugs to improve Alzheimer's disease (AD) from different pathways. As a supplement and alternative medicine, traditional Chinese medicine (TCM) targets multiple pathways which may be different from classical Western medicine, which may be orchestr...
Saved in:
Main Authors: | Xin-Yuan Du (Author), Yu-Shuang Cao (Author), Juan Yang (Author), Li-Chen Guo (Author), Tong Zhang (Author), Qing Yuan (Author), Xi Chen (Author), Li-min Hu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease
by: Nanbu Wang, et al.
Published: (2020) -
Therapeutic potential of Erxian decoction and its special chemical markers in depression: a review of clinical and preclinical studies
by: Ning-Xi Zeng, et al.
Published: (2024) -
Neuroprotective effect of β-asarone against Alzheimer’s disease: regulation of synaptic plasticity by increased expression of SYP and GluR1
by: Liu SJ, et al.
Published: (2016) -
Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors
by: Jun-Yong Wu, et al.
Published: (2018) -
α-Asarone Attenuates Osteoclastogenesis and Prevents Against Oestrogen-Deficiency Induced Osteoporosis
by: Hao Tian, et al.
Published: (2022)